title: MinION: A Novel Tool for Predicting Drug Hypersensitivity?
abstract: The launch of the MinION Access Program has caused much activity within the scientific community. MinION represents a keenly anticipated, novel addition to the current melange of commercial sequencers. Driven by the nanopore sequencing mechanism that requires minimal sample manipulation, the device is capable of generating long sequence reads in sizes (up to or exceeding 50 kb) that surpass those of all other platforms. One notable advantage of this feature is that long-range haplotypes can be more accurately resolved; such advantage is particularly pertinent to the genotyping of complex loci such as genes encoding the human leukocyte antigens, which are pivotal determinants of drug hypersensitivity. With this timely, albeit brief, review, we set out to examine the applications on which MinION has been tested thus far, the bioinformatics workflow tailored to the unique characteristics of its extended sequence reads, the device's potential utility in the detection of genetic markers for drug hypersensitivity, and how it may eventually evolve to become fit for diagnostic purposes in the clinical setting.
authors.affiliation: Faculty of Pharmacy, National University of Malaysia Kuala Lumpur, Malaysia.
authors.forename: Eng Wee
authors.initials: EW
authors.lastname: Chua
authors.affiliation: Faculty of Pharmacy, National University of Malaysia Kuala Lumpur, Malaysia.
authors.forename: Pei Yuen
authors.initials: PY
authors.lastname: Ng
keywords: MinION; bioinformatics analysis; drug hypersensitivity; nanopore sequencing; sequence-based HLA typing